EZH2 and cancer: Acknowledging that EZH2 possesses extensive cancer-promoting capabilities, a primary objective of future clinical and preclinical research lies in exploring the utilization of EZH2 inhibitors, aiming to maximize therapeutic outcomes by precisely targeting EZH2.